In vivo preclinical efficacy of MGD014 and MGD020 (HIV-1 envelope x CD3 DART molecules) and first-in-human phase 1 clinical safety evaluation of MGD014
Publication
, Conference
Nordstrom, JL; Gay, CL; Bohac, C; Wahl, AR; Morgan, T; Schmitz, JL; Li, H; Cotshott, J; Gobburu, J; Macintyre, AN; Gorelick, RJ; Ferrari, G ...
Published in: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
2022
Duke Scholars
Published In
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
EISSN
1758-2652
Publication Date
2022
Volume
25
Start / End Page
6 / 7
Related Subject Headings
- 4206 Public health
- 4202 Epidemiology
- 3202 Clinical sciences
- 1199 Other Medical and Health Sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Nordstrom, J. L., Gay, C. L., Bohac, C., Wahl, A. R., Morgan, T., Schmitz, J. L., … Garcia, J. V. (2022). In vivo preclinical efficacy of MGD014 and MGD020 (HIV-1 envelope x CD3 DART molecules) and first-in-human phase 1 clinical safety evaluation of MGD014. In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (Vol. 25, pp. 6–7).
Nordstrom, J. L., C. L. Gay, C. Bohac, A. R. Wahl, T. Morgan, J. L. Schmitz, H. Li, et al. “In vivo preclinical efficacy of MGD014 and MGD020 (HIV-1 envelope x CD3 DART molecules) and first-in-human phase 1 clinical safety evaluation of MGD014.” In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 25:6–7, 2022.
Nordstrom JL, Gay CL, Bohac C, Wahl AR, Morgan T, Schmitz JL, et al. In vivo preclinical efficacy of MGD014 and MGD020 (HIV-1 envelope x CD3 DART molecules) and first-in-human phase 1 clinical safety evaluation of MGD014. In: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2022. p. 6–7.
Nordstrom, J. L., et al. “In vivo preclinical efficacy of MGD014 and MGD020 (HIV-1 envelope x CD3 DART molecules) and first-in-human phase 1 clinical safety evaluation of MGD014.” JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, vol. 25, 2022, pp. 6–7.
Nordstrom JL, Gay CL, Bohac C, Wahl AR, Morgan T, Schmitz JL, Li H, Cotshott J, Gobburu J, Macintyre AN, Gorelick RJ, Ferrari G, Margolis DM, Garcia JV. In vivo preclinical efficacy of MGD014 and MGD020 (HIV-1 envelope x CD3 DART molecules) and first-in-human phase 1 clinical safety evaluation of MGD014. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2022. p. 6–7.
Published In
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
EISSN
1758-2652
Publication Date
2022
Volume
25
Start / End Page
6 / 7
Related Subject Headings
- 4206 Public health
- 4202 Epidemiology
- 3202 Clinical sciences
- 1199 Other Medical and Health Sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences